01-Sep-2020 - Georg-August-Universität Göttingen

Generation of human brain organoids with the ability to learn

Bioengineered Neuronal Organoids recapitulate important morphological features of the human brain

The brain is one of the most complex organs in the human body. Complexity of the brain is the result of highly and dynamically interconnected neurons as well as supporting glia. Lifelong changes in neuronal interconnectivity are key for memory and learning. Disturbances in neuronal interconnectivity underly neurodegenerative diseases.

Scientists from the Institute of Pharmacology and Toxicology at the University Medical Center Göttingen (UMG), in collaboration with colleagues from the Cluster of Excellence "Multiscale Bioimaging" (MBExC) and the German Center for Neurodegenerative Diseases (DZNE), have now succeeded for the first time in creating neuronal networks displaying the complex functions of the human brain from human induced pluripotent stem cells. These so-called Bioengineered Neuronal Organoids (BENOs) are thus suitable to study the loss of learning ability and memory in neurodegenerative diseases in more detail. Pharmacological and electrical stimuli were applied to confirm the classical developmental switch from an embryonic to a more advanced pattern of excitability.

The scientists exploited an array of assays to decipher the developmental complexity down to the cellular level in BENOs and could demonstrate the presence of key components of the human brain. “It was truly exciting to observe processes, which underly memory and learning, known as neuronal plasticity, in our BENO model”, says first author Dr. Maria-Patapia Zafeiriou, scientist at the Institute of Pharmacology and Toxicology, and member and application specialist at the MBExC. Prof. Dr. Wolfram-Hubertus Zimmermann, senior author, director of the Institute of Pharmacology and Toxicology and member of the MBExC adds “This first evidence for complex, physiological function in a lab-grown brain organoid will be further explored to study mechanisms and innovative therapies for degenerative diseases of the brain, such as stroke, epilepsia, and dementia”.

BENOs and first applications

BENOs are already finding initial applications in disease modelling, for example epilepsy syndromes, and drug testing. The availablity of induced pluripotent stem cells as the starting material for BENOs allows for the creation of BENOs from literally every individual, healthy and diseased. This opens the door for the development of patient-specific therapies. "This not only opens the door to the development and preclinical testing of individualised procedures directly on the human model. In principle, it will also be possible to cultivate replacement tissue for the treatment of patients suffering from neurodegenerative diseases," says Prof. Dr. Zimmermann.

Although our understanding of the human brain remains incomplete and, accordingly, therapeutic approaches to prevent or repair degeneration are largly insufficient, the availability of brain organoids with a cellular composition and function similar to the human brain will advance our understanding of how the human brain develops and functions properly as well as what causes neurodegeneration. The authors anticipate that the introduction of the BENO technology will support the search for innovative cures for todays most debilitating brain diseases. The University Medical Center Göttingen has filed a patent to protect the BENO technology and has licensed it to myriamed GmbH, a spin-off from the University Medical Center Göttingen, with a focus on drug discovery.

Facts, background information, dossiers
  • organoids
More about Uni Göttingen
  • News

    Are antivitamins the new antibiotics?

    Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago. Many diseases caused by bacterial infections - such as pneumonia, meningitis or septicaemia - are successfully treated with antibi ... more

    New insights into lung tissue in Covid-19 disease

    Physicists at the University of Göttingen, together with pathologists and lung specialists at the Medical University of Hannover, have developed a three-dimensional imaging technique that enables high resolution and three-dimensional representation of damaged lung tissue following severe Co ... more

    A chemical tailor-made suit for Alzheimer’s drugs

    With over 1.2 million people affected in Germany alone and over 50 million people worldwide, Alzheimer's disease, also referred to simply as Alzheimer's, is one of the greatest medical and social challenges of our time. Due to pathological changes in the brain, patients become increasingly ... more